Telesis Bio Inc. - TBIO Amount of Long-Term Liabilities

Brandmark of Codex DNA (TBIO)

Telesis Bio, Inc. (TBIO) has established a reputable image in synthetic biology through its benchtop gene printers, while its patent-protected software and consumables create a significant barrier to entry for competitors. This price chart illustrating value trends serves as an indicator of long-term debt, which stands at -0.06. The business relies on US-based production of automated systems that are in high demand within the scientific community and the pharmaceutical industry.

telesisbio.com (TBIO) Company Long-Term Debt: for the period 04/28/2023 - 10/05/2024

Summary analytical data breakdowns for Codex DNA (TBIO)

- market price and analyst price targets:
Stock Price telesisbio.com|TBIO - Consensus Target
- issuer market value details:
Market Value Telesis Bio|TBIO - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share Telesis Bio|TBIO - Company Book Value|Market Value to Book Value Ratio telesisbio.com|TBIO - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Telesis Bio, Inc.|TBIO - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Telesis Bio, Inc|TBIO - Company Aggregate Debts|Debts to Net Assets Telesis Bio|TBIO - Company Long-Term Debt|Short-Term Debt Volume Telesis Bio
Summary company analytics:TBIO telesisbio.com
Manufactured product of Telesis Bio, Inc.

Long-term debt reflects the total credit obligations with a maturity exceeding one year. This metric is calculated by aggregating non-current borrowings that are sensitive to quarterly balance sheet changes. The dynamics of the company's long-term liabilities allow for an assessment of the stability of its capital structure. For Telesis Bio, Inc. (TBIO), this tool is critical when planning R&D. Dependence on grants makes debt management a prerequisite for survival during cyclical downturns in demand for DNA synthesizers.

Competitors of Telesis Bio, Inc. (TBIO)

Company Long-Term Debts Tempus Labs TEM|QGEN: Company Long-Term Liabilities|Ionis Pharmaceuticals, Inc. - Amount of Long-Term Liabilities|RGEN: Company Long-Term Debts|Long-Term Debt Avidity Corp (RNA)|Company Long-Term Debt CRISPR Therapeutics AG|Company Long-Term Debt WGS|Company Long-Term Debts RARE|BEAM - Long-Term Debt|Company Long-Term Debt Sarepta Therapeutics Inc SRPT|Long-Term Debt Volume Twist Bioscience Corp (TWST)|10x Genomics, Inc. - Company Long-Term Debts|Long-Term Debt Volume intelliatx.com NTLA|Stoke Therapeutics, Inc. (STOK) - Company Long-Term Debt|BLFS - Long-Term Debt Volume|Company Long-Term Liabilities WVE|MAZE: Company Long-Term Loans and Borrowings|Company Long-Term Debts SION|Company Long-Term Debt PRME (primemedicine.com)|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|Long-Term Debt Volume uniQure NV (QURE)|MGTX - Company Long-Term Debt|Long-Term Debt REGENXBIO Corp|SLDB (Solid Biosciences Inc.) - Company Long-Term Liabilities|ocugen.com - Company Long-Term Loans and Borrowings|PACB (PacBio) - Company Long-Term Debts|Benitec Biopharma Inc (BNTC) - Long-Term Debt Volume|Company Long-Term Debt Design Pharma (DSGN)|Rocket Corp - Company Long-Term Indebtedness|Company Long-Term Debts FDMT (4D Molecular Therapeutics)|LXEO - Company Long-Term Liabilities|KRRO: Company Long-Term Liabilities|Long-Term Debt Volume Editas Medicine Inc EDIT|SLN (Silence Therapeutics Inc.) - Company Long-Term Liabilities|PRQR: Amount of Long-Term Liabilities|CDXS (Codexis Inc) - Company Long-Term Debts|Company Long-Term Debt SGMO|Company Long-Term Debts NAUT|Long-Term Debt Volume Metagenomi Inc.|Company Long-Term Debt Precision BioSciences DTIL|Generation Bio Co (GBIO) - Long-Term Debt|Boundless Bio, Inc. - Company Long-Term Debts|XCUR (Exicure, Inc.) - Company Long-Term Indebtedness|imunon.com (IMNN) - Company Long-Term Debt|Company Long-Term Indebtedness PHIO|MBIO (Mustang Bio Inc) - Company Long-Term Debts|Company Long-Term Debts TransCode|Company Long-Term Liabilities BNGO (Bionano Genomics, Inc.)|Amount of Long-Term Liabilities APDN|Company Long-Term Debts BLUE (bluebird bio)|ImmunoPrecise Antibodies Ltd (IPA) - Long-Term Debt|OMGA - Company Long-Term Debt|OMIC: Company Long-Term Debt|RGLS: Company Long-Term Debts|Long-Term Debt syros.com (SYRS)|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Unity Biotechnology Inc. (UBX) - Long-Term Debt Volume